Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Bifidobacterium longum & Colorectal cancer (CRC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Preclinical Data

Dietary administration of lyophilized cultures of B. longum resulted in signiﬁcant suppression of colon tumor incidence and tumor multiplicity and also reduced tumor volume in male F344 rats. Ingestion of Bifidobacterium longum signiﬁcantly inhibited azoxymethane (AOM) induced cell proliferation, ODC activity and expression of ras-p21 oncoprotein
Singh et al. 1997 Carcinogenesis 18: 833–41.

see also:
Probiotics (living agents) & Colorectal Cancer (CRC)
[Colorectal Cancer (CRC) & Dysbiosis](brain://dkYJhKz…

References (Sources)

Biﬁdobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis
Singh et al. 1997 Carcinogenesis 18: 833–41.
Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review
Han et al. 2018b Cancer Management and Research 10: 199-206
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!